Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: A novel approach to identifying patterns of human invasion-inhibitory antibodies guides the design of malaria vaccines incorporating polymorphic antigens

Fig. 3

Representative examples of differential growth inhibition of genetically engineered P. falciparum by human antibodies in the PNG study . Comparisons are shown of lines tested in parallel (3D7, FVO and HB3 (a) or W2mef, XIE and Pf2006 (b)) for inhibition by serum samples from malaria-exposed PNG individuals. Columns represent mean percentage growth inhibition (relative to control) of duplicate wells from a single experiment. Error bars indicate + SEM

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us